|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | |||||||||
| Cash and cash equivalents | |||||||||
| Short-term bank deposits | |||||||||
| Marketable securities | |||||||||
| Restricted cash | |||||||||
| Trade receivables | |||||||||
| Other receivables and prepaid expenses | |||||||||
| Deferred expenses related to issuance of warrants | |||||||||
| Inventories | |||||||||
| Total current assets | |||||||||
| LONG-TERM ASSETS: | |||||||||
| Long-term deposits and other receivables | |||||||||
| Deferred taxes | |||||||||
| Investment accounted for using the equity method | |||||||||
| Deferred expenses related to issuance of warrants | |||||||||
| Right-of-use-assets | |||||||||
| Property, plant and equipment, net | |||||||||
| Intangible assets, net | |||||||||
| Total long term assets | |||||||||
| TOTAL ASSETS | |||||||||
| LIABILITIES AND EQUITY | |||||||||
| CURRENT LIABILITIES: | |||||||||
| Trade payables | |||||||||
| Employees and payroll accruals | |||||||||
| Lease liabilities | |||||||||
| Liabilities in respect of government grants | |||||||||
| Deferred revenues and other advances | |||||||||
| Warrants and pre-funded warrants liability | |||||||||
| Convertible SAFE | |||||||||
| Other payables | |||||||||
| Total current liabilities | |||||||||
| LONG-TERM LIABILITIES: | |||||||||
| Lease liability | |||||||||
| Liabilities in respect of government grants | |||||||||
| Deferred revenues and other advances | |||||||||
| Convertible SAFE | |||||||||
| Total non-current liabilities | |||||||||
| TOTAL LIABILITIES | |||||||||
| SHAREHOLDERS' EQUITY: | |||||||||
| Ordinary shares of NIS 0.2 par value:Authorized – 30,000,000 ordinary shares; Issued and outstanding – 8,718,193 ordinary shares on December 31, 2025 and 6,514,589 ordinary shares on December 31, 2024 | |||||||||
| Share premium and other capital reserves | |||||||||
| Accumulated deficit | |||||||||
| Equity attributable to equity holders of the Company | |||||||||
| Non-controlling interests | |||||||||
| TOTAL EQUITY | |||||||||
| TOTAL LIABILITIES AND EQUITY | |||||||||
Loading...
